|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | NxStage Medical, Inc (Nasdaq: NXTM), a manufacturer of dialysis systems to treat end-stage renal disease and acute kidney failure. |
|---|---|
| Transferring Party | Medisystems Corporation, a maker and distributor of products for dialysis and related blood treatments. |
| Sector | Medical Devices |
| Date | June 4, 2007 |
| Analysis Medisystems is a U.S. market leader in hemodialysis blood tubing sets and related disposables, including the cartridge used in xStage's portable dialysis machine. For NxStage, the deal adds scale, production control and an experienced management. Deal value - $78.7m in NxState stock. Medsystems' revenues are $65.5 million in revenues (1.2x). | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |